GABAPENTIN
- Product NDC
- 43063-757
- 11-digit product format
- 430630757
- Labeler code
- 43063
- Product ID
- 43063-757_a449eb93-bf47-6b35-e053-2a95a90aff9c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- GABAPENTIN
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Application
- ANDA205101
- Marketing category
- ANDA
- Marketing start
- 2016-11-20
- Marketing end
- 0000-00-00
- Substance
- GABAPENTIN
- Active strength
- 600 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 43063-757-30 | EA - Each | 43063-757 | 381c6b08-6124-47af-a50d-1bdced1df172 | 1 | 2017-06-15 |
| 43063-757-60 | EA - Each | 43063-757 | 40d699db-5c40-4ca2-ba79-95f7504610cd | 1 | 2017-06-15 |
| 43063-757-83 | EA - Each | 43063-757 | ed600e48-20d7-4a0b-b2d7-df5f3cc56fd2 | 1 | 2017-06-15 |
| 43063-757-86 | EA - Each | 43063-757 | 41f10a38-c111-4ac5-ba92-c2413d1f066f | 1 | 2017-06-15 |
| 43063-757-90 | EA - Each | 43063-757 | fc0c849b-deb3-4946-a3f8-ea6e134dc497 | 1 | 2017-06-15 |
| 43063-757-93 | EA - Each | 43063-757 | b8aedfaa-78fc-4149-a320-a1212d686ff9 | 1 | 2017-06-15 |
| 43063-757-94 | EA - Each | 43063-757 | 1e1c5de6-6aef-4409-80d4-f5dba51c70f4 | 1 | 2017-06-15 |